Sofia I. Markoula

Prof. Sofia I. Markoula


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2008 in Acta Neurologica Scandinavica
Verified
Journal Article
Closed access
PDF file
LLL. Lazaros
L. Lazaros
SMSofia I. Markoula
Sofia I. Markoula
NXN. Xita
N. Xita
Sotirios GiannopoulosSotirios Giannopoulos
Sotirios Giannopoulos
PGP. Gogou
P. Gogou
Ioannis GeorgiouIoannis Georgiou
Ioannis Georgiou
The vascular protective effects of estrogens are mediated by their binding to the two known estrogen receptors. In this study, we examine the association of stroke with two common polymorphisms of the ESR1 gene in patients with metabolic syndrome. DNA from 130 patients hospitalized for ischemic stroke and 240 healthy controls were genotyped for ESR1 PvuII and XbaI polymorphisms. Results - Comparing female and male patients, it was found that CCGG diplotype is more frequent in male patients (P = 0.03). In addition, the AA genotype is associated with the onset of stroke at a younger age in the male patient group (P < 0.05). These findings suggest that PvuII and XbaI polymorphisms may affect the age at onset of the first stroke and the probability of developing cerebrovascular disease.

6 July 2020 in Acta Neurologica Scandinavica
Verified
Journal Article
Closed access
PDF file
SMSofia I. Markoula
Sofia I. Markoula
ESEleftheria Siarava
Eleftheria Siarava
CKCHARILAOS KOSTOULAS
CHARILAOS KOSTOULAS
AZAthanasios Zikopoulos
Athanasios Zikopoulos
Ioannis GeorgiouIoannis Georgiou
Ioannis Georgiou
Objectives The aim of the study was to assess whether, male patients with epilepsy, switching from valproic acid (VPA) to levetiracetam (LEV) or lamotrigine (LMG) critically improves sperm counts and parameters, increasing chance of patients' female partners to spontaneously conceive. Materials and methods This is an observational prospective study recruiting all consecutive infertile male patients with epilepsy followed up at the outpatient Epilepsy Clinic of University Hospital of Ioannina, Northwest Greece. Infertile couples were referred to the Laboratory of Assisted Reproduction and Treatment of the University Hospital of Ioannina to conduct semen analysis. The first sample was collected while the patients were receiving VPA, and the second semen sample was collected after the patients were switched to LEV or LMG. Results Seventeen infertile male patients were recruited in the study. Nine patients were switched to LEV, and eight patients were switched to LMG. The mean sperm count increased after VPA withdraw P = .06. Motility was improved with an increase of total motility and non‐progressive motility (P = .02 and P = .03, accordingly), whether sperm defects were decreased, mainly head defects (P = .03). Differences between patients switched to LEV or LMG were minimal and showed no significant findings. Spontaneous pregnancies were reported in three of the patients' partners, without any other clinical intervention offered to the couple. Conclusion Switching from valproic acid to levetiracetam or lamotrigine improved sperm counts and other sperm parameters in subfertile male patients and increased the chance of spontaneously conceiving in subfertile couples.

Verified
Journal Article
Open access
PDF file
PLParis Ladias
Paris Ladias
Georgios S. MarkopoulosGeorgios S. Markopoulos
Georgios S. Markopoulos
CKCHARILAOS KOSTOULAS
CHARILAOS KOSTOULAS
IBIoanna Bouba
Ioanna Bouba
SMSofia I. Markoula
Sofia I. Markoula
Ioannis GeorgiouIoannis Georgiou
Ioannis Georgiou
The PR domain-containing 9 or PRDM9 is a gene recognized for its fundamental role in meiosis, a process essential for forming reproductive cells. Recent findings have implicated alterations in the PRDM9, particularly its zinc finger motifs, in the onset and progression of cancer. This association is manifested through genomic instability and the misregulation of genes critical to cell growth, proliferation, and differentiation. In our comprehensive study, we harnessed advanced bioinformatic mining tools to delve deep into the intricate relationship between PRDM9F and cancer. We analyzed 136,752 breakpoints and found an undeniable association between specific PRDM9 motifs and the occurrence of double-strand breaks, a phenomenon evidenced in every cancer profile examined. Utilizing R statistical querying and the Regioner package, 55 unique sequence variations of PRDM9 were statistically correlated with cancer, from a pool of 1024 variations. A robust analysis using the Enrichr tool revealed prominent associations with various cancer types. Moreover, connections were noted with specific phenotypic conditions and molecular functions, underlining the pervasive influence of PRDM9 variations in the biological spectrum. The Reactome tool identified 25 significant pathways associated with cancer, offering insights into the mechanistic underpinnings linking PRDM9 to cancer progression. This detailed analysis not only confirms the pivotal role of PRDM9 in cancer development, but also unveils a complex network of biological processes influenced by its variations. The insights gained lay a solid foundation for future research aimed at deciphering the mechanistic pathways of PRDM9, offering prospects for targeted interventions and innovative therapeutic approaches in cancer management.

8 June 2020 in Future Oncology
Verified
Journal Article
Closed access
AKATHANASSIOS P KYRITSIS
ATHANASSIOS P KYRITSIS
SMSofia I. Markoula
Sofia I. Markoula
George A. AlexiouGeorge A. Alexiou
George A. Alexiou
AAAsimakis Asimakopoulos
Asimakis Asimakopoulos
PJPascal Jabbour
Pascal Jabbour
Chrissa SiokaChrissa Sioka
Chrissa Sioka
Limbic encephalitis is an inflammatory process involving the limbic structures of the brain, manifested with short-term memory deficits, confusion, depression and seizures. It is usually a paraneop...

Verified
Journal Article
Open access
PDF file
AZAthanasios Zikopoulos
Athanasios Zikopoulos
PKPeriklis Katopodis
Periklis Katopodis
MFMaria Filiponi
Maria Filiponi
AZAthanasios Zachariou
Athanasios Zachariou
ASAthanasia Sesse
Athanasia Sesse
Ioannis GeorgiouIoannis Georgiou
Ioannis Georgiou
Assisted reproductive technologies (ART) and, in particular, intracytoplasmic sperm injection (ICSI) transformed the management of male infertility by making fertility possible in previously untreatable cases. However, the bypassing of natural selection mechanisms at fertilization is fraught with the danger of transmission of genetic and epigenetic abnormalities. Male infertility is now a multifactorial disorder with notable contributions from single-gene defects, chromosomal abnormalities, and Y-chromosome microdeletions. The recent advances in next-generation sequencing and sperm omics have identified mutations and copy-number variations in genes critical for spermatogenesis, flagellar structure, and endocrine regulation. Along with these findings, an increasing body of evidence suggests that ART procedures can lead to a disruption of epigenetic reprogramming during gametogenesis and early embryogenesis, resulting in imprinting disorders and altered patterns of gene expression in the offspring. This review synthesizes recent progress in the molecular underpinnings of genetic and epigenetic hazards of ART, with an emphasis on clinical significance for reproductive counselling and ethical considerations for future generations.

14 March 2025 in Metabolic Brain Disease
Verified
Journal Article
Open access
PDF file
ASAthanasia Sesse
Athanasia Sesse
PLParis Ladias
Paris Ladias
CKCHARILAOS KOSTOULAS
CHARILAOS KOSTOULAS
DCDimitrios Chatzistefanidis
Dimitrios Chatzistefanidis
Ioannis GeorgiouIoannis Georgiou
Ioannis Georgiou
SMSofia I. Markoula
Sofia I. Markoula
More than 600 different metabolic disorders can lead to a clinical picture, where seizures are a main neurological manifestation, either as the primary clinical finding or as a part of a more complex phenotype. For these metabolic disorders, the term “metabolic epilepsy” is commonly used. About one in six metabolic epilepsies is treatable, constituting a well-defined subset of metabolic disorders, which is amenable to treatment targeting the primary cause of the seizures and reducing or preventing associated complications. However, the majority of metabolic disorders currently lack effective treatment, making them a major challenge both in clinical practice and in research. Herein, we provide an overview of both treatable and non-treatable metabolic epilepsies and discuss our current understanding of these disorders. We also perform pathway analysis in order to compare the pathways in which the genes associated with treatable and non-treatable metabolic epilepsies take part. This approach may orientate the research to particular pathways and explore novel treatment algorithms.